Matching orodispersible placebo tablet
P22-04 / BP1.7881
Phase 2 small_molecule active
Quick answer
Matching orodispersible placebo tablet for Eosinophilic esophagitis is a Phase 2 program (small_molecule) at Bioprojet Pharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bioprojet Pharma
- Indication
- Eosinophilic esophagitis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active